Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-013291
Filing Date
2023-04-18
Accepted
2023-04-18 16:28:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A acet-defa-2023.htm DEFA14A 18756
2 GRAPHIC img96100532_0.jpg GRAPHIC 72572
3 GRAPHIC img96100532_1.jpg GRAPHIC 48132
  Complete submission text file 0000950170-23-013291.txt   186299
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38359 | Film No.: 23827165
SIC: 2834 Pharmaceutical Preparations